These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 26319344)

  • 21. Vision loss in age-related maculopathy: primary care referral guide.
    Smith-Brewer S; Singerman LJ
    Geriatrics; 1987 Sep; 42(9):99-103, 106. PubMed ID: 3623111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New treatments for age-related macular degeneration.
    Mittra RA
    Minn Med; 2003 Apr; 86(4):40-6. PubMed ID: 12797657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [2/6--Age-related macular degeneration].
    Pierre-Kahn V
    Soins Gerontol; 2009; (76):45-6. PubMed ID: 19366028
    [No Abstract]   [Full Text] [Related]  

  • 24. [Age-related macular degeneration. Part 2: Therapeutic procedures].
    Wachtlin J; Gamulescu MA
    Klin Monbl Augenheilkd; 2012 Oct; 229(10):1049-59; quiz 1060-1. PubMed ID: 23225325
    [No Abstract]   [Full Text] [Related]  

  • 25. [Increased expression of endothelin-1-- a novel diagnostic marker for early AMD detection?].
    Machalińska A; Mozolewska-Piotrowska K; Paczkowska E; Lubiniski W
    Klin Oczna; 2014; 116(1):16-20. PubMed ID: 25137915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Age-related macular degeneration--contemporary possibilities of treatment].
    Studnicka J; Rencová E; Hejcmanová D; Korda V; Dusová J
    Acta Medica (Hradec Kralove) Suppl; 2004; 47(1):41-5. PubMed ID: 15745058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Eye's risk factors in age-related macular degeneration (AMD). Part II].
    Drobek-Słowik M; Karczewicz D; Safranow K
    Klin Oczna; 2008; 110(1-3):44-9. PubMed ID: 18669083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Age-related macular degeneration].
    Benyelles N; Soubrane G
    Rev Prat; 2006 Jun; 56(11):1194-201. PubMed ID: 16903520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drugs in Phase II clinical trials for the treatment of age-related macular degeneration.
    Tolentino MJ; Dennrick A; John E; Tolentino MS
    Expert Opin Investig Drugs; 2015 Feb; 24(2):183-99. PubMed ID: 25243494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.
    Klein R; Klein BE; Knudtson MD; Meuer SM; Swift M; Gangnon RE
    Ophthalmology; 2007 Feb; 114(2):253-62. PubMed ID: 17270675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinal vascular caliber, iris color, and age-related macular degeneration in the Irish Nun Eye Study.
    McGowan A; Silvestri G; Moore E; Silvestri V; Patterson CC; Maxwell AP; McKay GJ
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):382-7. PubMed ID: 25525170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poor responders to bevacizumab pharmacotherapy in age-related macular degeneration and in diabetic macular edema demonstrate increased risk for obstructive sleep apnea.
    Nesmith BL; Ihnen M; Schaal S
    Retina; 2014 Dec; 34(12):2423-30. PubMed ID: 25062438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth U; Waldstein SM; Deak GG; Kundi M; Simader C
    Ophthalmology; 2015 Apr; 122(4):822-32. PubMed ID: 25578255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Eye's risk factors in age-related macular degeneration (AMD). Part I].
    Drobek-Słowik M; Karczewicz D; Safrano K
    Klin Oczna; 2008; 110(1-3):40-3. PubMed ID: 18669082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Frequency of neovascular lesion types in wet age-related macular degeneration].
    Gierek-Lapińska A; Wykrota H; Trzciakowski K; Szymkowiak M; Gierek-Ciaciura S
    Klin Oczna; 2004; 106(3 Suppl):463-5. PubMed ID: 15636237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-related macular degeneration: diagnosis and management.
    Cook HL; Patel PJ; Tufail A
    Br Med Bull; 2008; 85():127-49. PubMed ID: 18334518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Age-related macular degeneration].
    Van Bol L; Rasquin F
    Rev Med Brux; 2014 Sep; 35(4):265-70. PubMed ID: 25675629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Age-related macular degeneration--new possibilities for prophylactic measures].
    Frennesson C; Nilsson SE
    Lakartidningen; 2002 Aug; 99(32-33):3194-7. PubMed ID: 12219472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments.
    Rein DB; Wittenborn JS; Zhang X; Honeycutt AA; Lesesne SB; Saaddine J;
    Arch Ophthalmol; 2009 Apr; 127(4):533-40. PubMed ID: 19365036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent developments in age-related macular degeneration: a review.
    Al-Zamil WM; Yassin SA
    Clin Interv Aging; 2017; 12():1313-1330. PubMed ID: 28860733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.